Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6,986,000 | 6,105,000 | 6,839,000 | 6,652,000 | 6,594,000 |
| Cost of Goods | 1,813,000 | 1,720,000 | 1,747,000 | 1,588,000 | 1,510,000 |
| Gross Profit | 5,173,000 | 4,385,000 | 5,092,000 | 5,064,000 | 5,084,000 |
| Operating Expenses | 2,489,000 | 2,464,000 | 2,862,000 | 2,404,000 | 2,908,000 |
| Operating Income | 2,684,000 | 1,921,000 | 2,230,000 | 2,660,000 | 2,176,000 |
| Interest Expense | 752,000 | 543,000 | 415,000 | 368,000 | 328,000 |
| Other Income | -318,000 | 2,064,000 | -67,000 | 100,000 | -317,000 |
| Pre-tax Income | 1,614,000 | 3,442,000 | 1,748,000 | 2,392,000 | 1,531,000 |
| Income Tax | 235,000 | 601,000 | 132,000 | 249,000 | 214,000 |
| Net Income Continuous | 1,379,000 | 2,841,000 | 1,616,000 | 2,143,000 | 1,317,000 |
| Net Income | $1,379,000 | $2,841,000 | $1,616,000 | $2,143,000 | $1,317,000 |
| EPS Basic Total Ops | 2.58 | 5.32 | 3.02 | 4.01 | 2.46 |
| EPS Basic Continuous Ops | 2.58 | 5.32 | 3.02 | 4.01 | 2.46 |
| EPS Diluted Total Ops | 2.57 | 5.28 | 3.00 | 3.98 | 2.45 |
| EPS Diluted Continuous Ops | 2.57 | 5.28 | 3.00 | 3.98 | 2.45 |
| EPS Diluted Before Non-Recurring Items | 5.00 | 3.98 | 4.09 | N/A | N/A |
| EBITDA(a) | $3,580,000 | $2,821,000 | $3,141,000 | $3,497,000 | $3,004,000 |